Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists

Sarah C. Archibald, John C. Head, Neil Gozzard, David W. Howat, Ted A H Parton, John R. Porter, Martyn K. Robinson, Anthony Shock, Graham J. Warrellow, William M. Abraham

Research output: Contribution to journal › Article

25 Citations (Scopus)

Abstract

Using disulphide cysteine-based inhibitors as lead structures, this communication describes our strategy for identifying more stable, potent antagonists of the α4β1 integrin. These studies ultimately discovered potent, low molecular weight inhibitors based on D-thioproline-L-tyrosine. (C) 2000 Elsevier Science Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)997-999
Number of pages3
JournalBioorganic and Medicinal Chemistry Letters
Volume10
Issue number9
DOIs
StatePublished - May 1 2000
Externally publishedYes

Fingerprint

Integrins
Disulfides
Cysteine
Tyrosine
Molecular Weight
Molecular weight
Communication
thiazolidine-4-carboxylic acid

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Archibald, S. C., Head, J. C., Gozzard, N., Howat, D. W., Parton, T. A. H., Porter, J. R., ... Abraham, W. M. (2000). Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists. Bioorganic and Medicinal Chemistry Letters, 10(9), 997-999. https://doi.org/10.1016/S0960-894X(00)00147-5

Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists. / Archibald, Sarah C.; Head, John C.; Gozzard, Neil; Howat, David W.; Parton, Ted A H; Porter, John R.; Robinson, Martyn K.; Shock, Anthony; Warrellow, Graham J.; Abraham, William M.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 10, No. 9, 01.05.2000, p. 997-999.

Research output: Contribution to journal › Article

Archibald, SC, Head, JC, Gozzard, N, Howat, DW, Parton, TAH, Porter, JR, Robinson, MK, Shock, A, Warrellow, GJ & Abraham, WM 2000, 'Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists', Bioorganic and Medicinal Chemistry Letters, vol. 10, no. 9, pp. 997-999. https://doi.org/10.1016/S0960-894X(00)00147-5
Archibald SC, Head JC, Gozzard N, Howat DW, Parton TAH, Porter JR et al. Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists. Bioorganic and Medicinal Chemistry Letters. 2000 May 1;10(9):997-999. https://doi.org/10.1016/S0960-894X(00)00147-5
Archibald, Sarah C. ; Head, John C. ; Gozzard, Neil ; Howat, David W. ; Parton, Ted A H ; Porter, John R. ; Robinson, Martyn K. ; Shock, Anthony ; Warrellow, Graham J. ; Abraham, William M. / Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists. In: Bioorganic and Medicinal Chemistry Letters. 2000 ; Vol. 10, No. 9. pp. 997-999.
@article{7721cd05b9ac450ba5b68fe1f7ed2425,
title = "Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists",
abstract = "Using disulphide cysteine-based inhibitors as lead structures, this communication describes our strategy for identifying more stable, potent antagonists of the α4β1 integrin. These studies ultimately discovered potent, low molecular weight inhibitors based on D-thioproline-L-tyrosine. (C) 2000 Elsevier Science Ltd. All rights reserved.",
author = "Archibald, {Sarah C.} and Head, {John C.} and Neil Gozzard and Howat, {David W.} and Parton, {Ted A H} and Porter, {John R.} and Robinson, {Martyn K.} and Anthony Shock and Warrellow, {Graham J.} and Abraham, {William M.}",
year = "2000",
month = "5",
day = "1",
doi = "10.1016/S0960-894X(00)00147-5",
language = "English",
volume = "10",
pages = "997--999",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Discovery and evaluation of potent, tyrosine-based α4β1 integrin antagonists

AU - Archibald, Sarah C.

AU - Head, John C.

AU - Gozzard, Neil

AU - Howat, David W.

AU - Parton, Ted A H

AU - Porter, John R.

AU - Robinson, Martyn K.

AU - Shock, Anthony

AU - Warrellow, Graham J.

AU - Abraham, William M.

PY - 2000/5/1

Y1 - 2000/5/1

N2 - Using disulphide cysteine-based inhibitors as lead structures, this communication describes our strategy for identifying more stable, potent antagonists of the α4β1 integrin. These studies ultimately discovered potent, low molecular weight inhibitors based on D-thioproline-L-tyrosine. (C) 2000 Elsevier Science Ltd. All rights reserved.

AB - Using disulphide cysteine-based inhibitors as lead structures, this communication describes our strategy for identifying more stable, potent antagonists of the α4β1 integrin. These studies ultimately discovered potent, low molecular weight inhibitors based on D-thioproline-L-tyrosine. (C) 2000 Elsevier Science Ltd. All rights reserved.

UR - http://www.scopus.com/inward/record.url?scp=17144433994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144433994&partnerID=8YFLogxK

U2 - 10.1016/S0960-894X(00)00147-5

DO - 10.1016/S0960-894X(00)00147-5

M3 - Article

VL - 10

SP - 997

EP - 999

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 9

ER -

Access to Document